10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,195,956 | -26.1% | 150,205 | +0.0% | 0.12% | -24.7% |
| Q2 2023 | $8,386,945 | +0.1% | 150,196 | -0.0% | 0.17% | -5.7% |
| Q1 2023 | $8,379,993 | +35.1% | 150,206 | -11.8% | 0.18% | +25.7% |
| Q4 2022 | $6,202,307 | +3.6% | 170,206 | -19.0% | 0.14% | -5.4% |
| Q3 2022 | $5,984,000 | -37.1% | 210,123 | 0.0% | 0.15% | -33.6% |
| Q2 2022 | $9,508,000 | -40.5% | 210,123 | 0.0% | 0.22% | -32.4% |
| Q1 2022 | $15,985,000 | -49.0% | 210,123 | -0.0% | 0.33% | -47.7% |
| Q4 2021 | $31,313,000 | – | 210,209 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |